Innovation Pharmaceuticals Inc. · OTC:IPIX

Innovation Pharmaceuticals Inc. financial statements

Innovation Pharmaceuticals Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue18.0K18.0K23.0K423.0K000000
Cost of revenue373.0K382.0K378.0K371.0K413.0K406.0K420.0K00
Gross profit-373.0K18.0K-378.0K423.0K-371.0K-413.0K-406.0K-420.0K00
Research and development1.46M4.81M6.64M2.79M4.34M11.4M12.8M8.95M10.5M6.34M
Selling, general and administrative995.0K1.96M2.00M2.27M2.11M2.58M2.55M3.05M2.42M1.69M
Operating income-172.0K-6.92M-9.02M-4.63M-6.45M-13.9M-15.3M-12.7M-13.0M-8.04M
Depreciation and amortization373.0K382.0K378.0K373.0K371.0K413.0K405.0K420.0K404.0K289.0K
EBITDA201.0K-6.54M-8.64M-4.26M-6.08M-13.5M-14.9M-12.2M-12.6M-7.75M
Interest expense28.0K115.0K4.86M260.0K2.20M202.0K202.0K202.0K202.0K210.0K
Income before tax-3.17M-7.04M-13.9M-6.65M-8.68M-16.4M-15.5M-12.9M-13.1M-8.25M
Income tax172.0K120.0K4.86M362.0K390.0K-2.22M198.0K202.0K202.0K1.00K
Net income-3.17M-7.04M-13.9M-6.65M-9.07M-16.4M-15.5M-12.9M-13.1M-8.25M
Earnings per share, basic-0.01-0.01-0.04-0.03-0.05-0.11-0.12-0.11-0.11-0.08

Balance sheet

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash and equivalents1.52M3.81M10.2M6.02M579.0K2.42M4.14M6.31M8.41M4.99M
Short-term investments78.0K
Receivables29.0K26.0K26.0K12.0K
Inventory49.0K-26.0K-26.0K-12.0K
Current assets1.63M3.95M10.7M6.11M625.0K2.60M4.47M6.69M8.77M5.56M
Property, plant and equipment1.00K2.00K120.0K90.0K38.0K39.0K
Total assets7.52M10.4M14.3M9.25M4.05M6.54M9.11M11.4M14.3M10.9M
Accounts payable1.50M1.08M1.08M557.0K641.0K1.68M105.0K57.0K1.84M43.0K
Current liabilities5.02M4.81M6.54M7.37M7.30M8.69M10.6M8.48M7.29M9.65M
Long-term debt879.0K
Total debt725.0K1.29M1.87M2.46M1.92M2.02M2.02M2.02M2.02M2.02M
Total liabilities5.48M5.65M6.79M7.79M8.18M8.69M10.6M8.48M7.29M9.65M
Shareholders' equity2.04M4.73M7.51M1.46M-4.13M-2.15M-1.46M2.96M7.02M1.21M
Shares outstanding505.8M503.9M386.2M237.3M178.2M144.5M127.3M119.9M115.1M105.0M

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations-2.11M-6.28M-9.49M-4.16M-6.33M-13.3M-11.7M-9.89M-13.1M-7.51M
Capital spending-60.0K-80.0K-72.0K-91.0K-86.0K-117.0K-336.0K-414.0K-459.0K-2.67M
Free cash flow-2.17M-6.36M-9.57M-4.25M-6.42M-13.4M-12.0M-10.3M-13.5M-10.2M
Cash from investing-60.0K-4.08M-72.0K-91.0K-46.0K-104.0K-336.0K-414.0K-459.0K-2.65M
Cash from financing-123.0K3.97M13.7M9.69M4.53M11.7M9.88M8.20M17.0M12.2M
Dividends paid-86.0K-86.0K-86.0K-9.82M-4.62M
Share buybacks0-670.0K-55.0K-91.0K-172.0K-220.0K8.20M17.0M12.5M
Change in cash-2.29M-6.39M4.18M5.44M-1.84M-1.72M-2.17M-2.10M3.42M2.03M